Low sodium intake induces an increase in renal monoamine oxidase activity in the rat. Involvement of an angiotensin II dependent mechanism

Acta Physiologica Scandinavica

Volumn 185, Issue 2, 2005, Pages 161-167

  De Luca Sarobe, V ^a   Nowicki, S ^b   Carranza, A ^b   Levin, G ^b   Barontini, M ^b   Arrizurieta, E ^b   Ibarra, F R ^b,c  

^a INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

^b HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^c NONE   (Argentina)

Author keywords

Angiotensin II; Dopamine; Low sodium intake; Renal dopamine; Renal monoamine oxidase; Sodium excretion

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); ANGIOTENSIN; AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPAMINE; LOSARTAN; SODIUM;

ANIMAL EXPERIMENT; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINE URINE LEVEL; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM INTAKE; SODIUM RESTRICTION; SODIUM URINE LEVEL;

3,4-DIHYDROXYPHENYLACETIC ACID; ALDOSTERONE; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; DIET, SODIUM-RESTRICTED; DOPAMINE; GLOMERULAR FILTRATION RATE; KIDNEY; LOSARTAN; MALE; MONOAMINE OXIDASE; RATS; RATS, WISTAR; SODIUM;

EID: 25844523703     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-201X.2005.01473.x     Document Type: Article

References (35)

1. Aperia, A.C. 2000. Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 62, 621-647.
2. +-ATPase: a final common pathway for regulation of natriuresis. FASEB J 8, 436-439.
3. Armando, I., Levin, G. & Barontini, M. 1988. Stress increases endogenous benzodiapine receptor ligand-monoamine oxidase inhibitory activity (tribulin) in rat tissues. J Neural Trasm 71, 29-37.
4. Belloni, A.S., Andreis, P.G., Macchi, V., Gottardo, G., Malendowicz, L.K. & Nussdorfer, G.G. 1998. Distribution and functional significance of angiotensin-II AT1- and AT2-receptor subtypes in the rat adrenal gland. Endocr Res 24, 1-15.
5. +-ATPase phosphorylation by PKC in the medullary thick ascending limb of Henle in the rat. Pflügers Archiv 447, 87-96.
6. Bompart, G., Copin, N., Djouadi, F., Bastin, J., Ordener, C. & Parini, A. 2001. Monoamine oxidase in developing rat renal cortex: effect of dexamethasone treatment. Eur J Pharmacol 415, 19-26.
7. Chen, C.J., Apparsundaram, S. & Lokhandwala, M.F. 1991. Intrarenally produced Angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats. J Pharmacol Exp Ther 256, 486-491.
8. Cheng, H.F., Becker, B.N. & Harris, R.C. 1996. Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest 97, 2745-2752.
9. Efendiev, R., Budu, C.E., Cinelli, A.R., Bertorello, A.M. & Pedemonte, C.H. 2003. Intracellular Na+ regulates dopamine and angiotensin II receptors availability at the plasma membrane and their cellular responses in renal epithelia. J Biol Chem 278, 28719-28726.
10. Eisenhofer, G., Goldstein, D.S., Stull, R. et al. 1986. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem 32, 2030-2033.
11. Fernandez, B.E. & Dominguez, A.E. 1991. Angiotensin II increases MAO activity in rat central nervous system. Rev Esp Fisiol Mar 47, 37-40.
12. Fernandez, M.H. & Soares-da-Silva, P. 1990. Effects of MAO-A and MAO-B selective inhibitors on the deamination of newly formed dopamine in the rat kidney. J Pharmacol Exp Ther 255, 1309-1313.
13. Fernandez, M.H. & Soares-da-Silva, P. 1992. Type A and B monoamine oxidase activities in the human and rat kidney. Acta Physiol Scand 145, 363-367.
14. Fernandez, M.H. & Soares-da-Silva, P. 1994. Role of monoamine oxidase and catechol-O-methyltransferase in the metabolism of renal dopamine. J Neural Transm Suppl 41, 101-105.
15. Guron, G., Nilsson, A., Dibona, G.F., Sundelin, B., Nitescu, N. & Friberg, P. 1997. Renal adaptation to dietary sodium restriction and loading in rats treated neonatally with enalapril. Am J Physiol 273, R1421-R1429.
16. Hansell, P., Odlind, C. & Mannisto, P.T. 1998. Different renal effects of two inhibitors of catechol-O-methylation in the rat: entacapone and CGP 28014. Acta Physiol Scand 162, 489-494.
17. Hayashi, M., Yamaji, Y., Kitajima, W. & Saruta, T. 1990. Aromatic L-amino acid decarboxylase activity along the rat nephron. Am J Physiol 258, F28-F33.
18. Ibarra, F.R., Galceran, T., Oddo, E. & Arrizurieta, E. 1998. Changes in glomerular filtration rate and renal plasma flow during converting enzyme inhibition in cirrhotic rats. Ren Fail 20, 65-74.
19. Ibarra, F.R., Armando, I., Nowicki, S. et al. 2005. Dopamine is metabolised by different enzymes along the rat nephron. Pflügers Arch 450, 185-191.
20. Jose, P.A., Raymond, J.R., Bates, M.D., Aperia, A., Felder, R.A. & Carey, R.M. 1992. The renal dopamine receptors. J Am Soc Nephrol 2, 1265-1278.
21. Kalaria, R.N. & Harik, S.I. 1987. Differential postnatal development of monoamine oxidases A and B in the blood-brain barrier of the rat. J Neurochem 49, 1589-1594.
22. Kaschina, E. & Unger, T. 2003. Angiotensin AT1/AT2 receptors: regulation, signaling and function. Blood Press 12, 70-88.
23. Pizzinat, N., Remaury, A. & Parini, A. 1998. The renal monoamine oxidases: pathophysiology and targets for therapeutic intervention. Curr Opin Nephrol Hypertens 7, 33-36.
24. Pizzinat, N., Marchal-Victorion, S., Maurel, A., Ordener, C., Bompart, G. Parini, A. 2003. Substrate-dependent regulation of monoamine oxidase A in rat mesangial cells: involvement of dopamine D2-like receptors. Am J Physiol 284, F167-F174.
25. Raasch, W., Bartels, T., Gieselberg, A., Dendorfer, A. & Dominiak, P. 2002. Angiotensin I converting enzyme inhibition increases cardiac catecholamine content and reduces monoamine oxidase activity via an angiotensin type 1 receptor-mediated mechanism. J Pharmacol Exp Ther 300, 428-434.
26. Shih, J.C., Chen, K. & Ridd, M.J. 1999. Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 22, 197-217.
27. Smith, H.W., Finkelstein, N., Aliminosa, L., Crawford, B. & Graber, M. 1945. The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 24, 388.
28. Tomaszewicz, M., Micossi, L.G., Bielarczyk, H., Luszawska, D., Santarelli, I. & Szutowicz, A. 1991. Differential effects of angiotensin II and eledoisin on monoamine oxidase A and B activities in rat brain. J Neurochem 56, 729-732.
29. Treeck, B., Roald, A.B., Tenstad, O. & Aukland, K. 2002. Effect of exogenous and endogenous angiotensin II on intrarenal distribution of glomerular filtration rate in rats. J Physiol 541, 1049-1057.
30. Vieira-Coelho, M.A., Hussain, T., Kansra, V. et al. 1999. Aging, high salt intake, and renal dopaminergic activity in Fischer 344 rats. Hypertension 34, 666-672.
31. Wang, D.H. & Li, J. 2000. Regulation of angiotensin II receptors in the medullary thick ascending limb. Mol Cell Biochem 212, 211-217.
32. Wang, Y., Berndt, T.J., Gross, J.M., Peterson, M.A., So, J.M. & Knox, F.G. 2001. Effect of inhbition of MAO and COMT on intrarenal dopamine and serotonin and on renal function. Am J Physiol 280, R248-R254.
33. Yong, D., Aqing, Y., Dengfu, G., Tadashi, I. & Wang, D.H. 1995. Differential regulation of angiotensin II receptor subtypes in rat kidney by low dietary sodium. Hypertension 25, 872-877.
34. Young, M.K. & Raiz, L.S. 1952. The Anthrone method. Proc Soc Exper Biol Med 80, 1771.
35. Zeng, C., Luo, Y., Asico, L.D. et al. 2003. Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats hypertension. Hypertension 42, 787-792.